The efficacy and safety of isepamicin and ceftazidime compared with amikacin and ceftazidime in acute lower respiratory tract infection.

Abstract

Isepamicin is a new aminoglycoside antibiotic which has a superior stability to aminoglycoside-inactivating enzymes compared with other available aminoglycosides. In this multicentre, randomised, open study, the safety and efficacy of isepamicin plus ceftazidime was compared with that of amikacin plus ceftazidime in adults with acute lower respiratory tract… (More)

Topics

Cite this paper

@article{Colardyn1995TheEA, title={The efficacy and safety of isepamicin and ceftazidime compared with amikacin and ceftazidime in acute lower respiratory tract infection.}, author={Francis A. Colardyn}, journal={Journal of chemotherapy}, year={1995}, volume={7 Suppl 2}, pages={129-35} }